Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease

Biochemistry

Volumn 47, Issue 45, 2008, Pages 11763-11770

  Tomlinson, Suzanne M ^a   Watowich, Stanley J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BINDING ENERGY; BINDING SITES; BIOCHEMISTRY; REACTION KINETICS; VIRUSES;

ANTIVIRAL DRUGS; BINDING SURFACES; DRUG DISCOVERIES; INHIBITION MECHANISMS; KINETIC DATUMS; NORTH AMERICA; PEPTIDE INHIBITORS; PEPTIDE SUBSTRATES; PRODUCT INHIBITIONS; PROTEASE ASSAYS; REACTION PRODUCTS; SUBSTRATE ANALOGUES; SUBSTRATE INHIBITIONS; VIRUS REPLICATIONS; WEST NILE VIRUSES;

SUBSTRATES;

NS2B NS3 PROTEASE; PROTEINASE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; ENZYME ACTIVE SITE; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE COMPLEX; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; WEST NILE FLAVIVIRUS;

BINDING SITES; CATALYSIS; KINETICS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE VIRUS;

ANIMALIA; FLAVIVIRUS; WEST NILE VIRUS;

EID: 55849123292     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801034f     Document Type: Article

References (41)

1. Campbell, G., Marfin, A., Lanciotto, R., and Gubler, D. (2002) West Nile virus. Lancet Infect. Dis. 2, 519-529.
2. Fields, B., Knipe, D., Howley, P., Chanock, R., Melnick, J., Monath, T., Roizman, B., and Strauss, S. (1996) Flaviviruses, in Field's Virology, 3rd, ed, pp 961-1034, Lippincott Williams & Wilkins, Philadelphia, PA.
3. Brinton, M. A. (2002) The molecular biology of West Nile virus: a new invader of the Western hemisphere. Annu. Rev. Microbiol. 56, 371-402.
4. Hurlbut, H., Rizk, F., Taylor, R., and Work, T. (1956) A study of the ecology of West Nile virus in Egypt. Am. J. Trop. Med. Hyg. 5, 579-620.
5. McIntosh, B., Madsen, W., and Dickinson, D. (1969) Ecological studies on Sindbis and West Nile viruses in South Africa. VI. The antibody response of wild birds. S. Afr. J. Med. Sci. 34, 83-91.
6. Pfleiderer, C., Blumel, J., Schmidt, M., Roth, W., Houfar, M., Eckert, J., Chudy, M., Menichetti, E., Lechner, S., and Nubling, C. (2008) West Nile virus and blood product safety in Germany. J. Med. Virol. 80, 557-563.
7. Del Giudice, P., Schuffenecker, I., Vandenbos, F., Counillon, E., and Zellet, H. (2004) Human West Nile virus, France. Emerg. Infect. Dis. 10, 1885-1886.
8. Samina, I., Margalit, J., and Peleg, J. (1986) Isolation of viruses from mosquitoes of the Negev, Israel. Trans. R. Soc. Trop. Med. Hyg. 80, 471-472.
9. Ozer, N., Ergunay, K., Simsek, F., Kaynas, S., Alten, B., Caglar, S., and Ustacelebi, S. (2007) West Nile virus studies in the Sanliurfa province of Turkey. J. Vector. Ecol. 32, 202-206.
10. Weinberger, M., Pitlik, S., Gandacu, D., Lang, R., Nassar, F., Ben, D., Rubinstein, E., Izthaki, A., Mishal, J., Kitzes, R., Siegman-Ingra, Y., Giladi, M., Pick, N., Mendelson, E., Bin, H., and Shohat, T. (2001) West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg. Infect. Dis. 7, 686-691.
11. Bondre, V., Jadi, R., Mishra, A., Yergolkar, P., and Arankalle, V. (2007) West Nile virus isolates from India: evidence for a distinct genetic lineage. J. Gen. Virol. 88, 875-884.
12. Lanciotti, R., Roehrig, J., Deubel, V., Smith, J., Parker, M., Steele, K., Crise, B., Volpe, K., Crabtree, M., Scherret, J., Hall, R., Mackenzie, J., Cropp, C., Panigrahy, B., Ostlund, E., Schmitt, B., Malkinson, M., Banet, C., Weissman, J., Komar, N., Savage, H., Stone, W., McNamara, T., and Gubler, D. (1999) Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286, 2333-2337.
13. Deardorff, E., Estrada-Franco, J., Brault, A., Navarro-Lopez, R., Campomanes-Cortes, A., Paz-Ramirez, P., Solis-Hernandez, M., Ramey, W., Davis, C., Beasley, D., Tesh, R., Barrett, A., and Weaver, S. (2006) Introductions of West Nile virus strains to Mexico. Emerg. Infect. Dis. 12, 314-318.
14. Berrocal, L., Pena, J., Gonzalez, M., and Mattar, S. (2006) West Nile virus; ecology and epidemiology of an emerging pathogen in Colombia. Rev. Salud Publica (Bogata) 8, 218-228.
15. Schellenberg, T., erson, M., Drebot, M., Vooght, M., Findlater, A., Curry, P., Campbell, C., and Osei, W. (2006) Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can. J. Public Health 97, 369-373.
16. Chambers, T., Nestorowics, A., Amberg, S., and Rice, C. (1993) Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication. J. Virol. 67, 6797-6807.
17. Falgout, B., Pethel, M., Zhang, Y., and Lai, C. (1991) Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J. Virol. 65, 2467-2475.
18. Leyssen, P., de Clercq, E., and Neyts, J. (2000) Perspectives for the treatment of infections with Flaviviridae. Clin. Microbiol. Rev. 13, 67-82.
19. D'Arcy, A., Chaillet, M., Schiering, N., Villard, F., Pheng Lim, S., Lefeuvre, P., and Erbel, P. (2006) Purification and crystallization of dengue and West Nile virus NS2B-NS3 complexes. Acta. Crystallogr. 62, 157-162.
20. Aleshin, A. E., Shiryaev, S. A., Strongin, A. Y., and Liddington, R. C. (2007) Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci. 16, 795-806.
21. Murthy, H., Clum, S., and Padmanabhan, R. (1999) Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects. J. Biol. Chem. 274, 5573-5580.
22. Murthy, H., Judge, K., Delucas, L., and Padmanabhan, R. (2000) Crystal structure of dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design. J. Mol. Biol. 301, 759-767.
23. Leung, D., Schroder, K., White, H., Fang, N. X., Stoermer, M. J., Abbenante, G., Martin, J. L., Young, P. R., and Fairlie, D. P. (2001) Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J. Biol. Chem. 276, 45762-45771.
24. Knox, J., Ling Ma, N., Yin, Z., Patel, S., Wang, W., Chan, W., Rao, K., Wang, G., Ngew, X., Patel, V., Beer, D., Pheng Lim, S., Vasudevan, S., and Keller, T. (2006) Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors. J. Med. Chem. 49, 6585-6590.
25. Ganesh, V. K., Muller, N., Judge, K., Luan, C. H., Padmanabhan, R., and Murthy, K. H. (2005) Identification and characterization of nonsubstrate-based inhibitors of the essential dengue and West Nile virus proteases. Bioorg. Med. Chem. 13, 257-264.
26. Yusof, R., Clum, S., Wetzel, M., Murthy, H., and Padmanabhan, R. (2000) Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J. Biol. Chem. 275, 9963-9969.
27. Mueller, N. H., Yon, C., Ganest, V. K., and Padmanabhan, R. (2007) Characterization of the West Nile virus protease substrate specificity and inhibitors. Int. J. Biochem. Cell Biol. 39, 606-614.
28. Chappell, K., Nall, T., Stoermer, M., Fang, N., Tyndall, J., Fairlie, D., and Young, P. (2005) Site-directed mutagenesis and kinetic studies of the West Nile virus NS3 protease identify key enzyme-substrate interactions. J. Biol. Chem. 28, 2896-2903.
29. Chapell, K., Stoermer, M., Fairlie, D., and Young, P. (2007) Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3. Protein Expression Purif. 53, 87-96.
30. Bera, A. K., Juhn, R. J., and Smith, J. L. (2007) Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease. J. Biol. Chem. 282, 12883-12892.
31. Nall, T., Chappell, K., Stoermer, M., Fang, N., Tyndall, J., Young, P., and Fairlie, D. (2004) Enzymatic characterization of a homology model of a catalytically active recombinant West Nile virus NS3 protease. J. Biol. Chem. 279, 48535-48542.
32. Shiryaev, S., Ratnikov, B., Aleshin, A., Kozlov, I., Nelson, N., Lebl, M., Smith, J., Liddington, R., and Strongin, A. (2007) Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure based mutagenesis. J. Virol. 81, 4501-4509.
33. Chanprapaph, S., Saparpakorn, P., Sangma, C., Niyomrattanakit, P., Hannongbua, S., Angsuthanasombat, C., and Katzenmeier, G. (2005) Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites. Biochem. Biophys. Res. Commun. 330, 1237-1246.
34. Kuzmic, P. (1996) Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase. Anal. Biochem. 237, 260-273.
35. Segel, I. (1993) Kinetics of Unireactant Enzymes, in Enzyme Kinetics Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, Wiley Classics Library ed., pp 18-89, John Wiley & Sons, Inc., New York.
36. Kuzmic, P., Cregar, L., Millis, S., and Gopldman, M. (2006) Mixed-type noncompetitive inhibition of lethal factor protease by aminoglycosides. FEBS J. 273, 3054-3062.
37. Turk, B. (2008) Discovery and development of anthrax lethal factor metalloproteinase inhibitors. Curr. Pharm. Biotechnol. 9, 24-33.
38. Lai, L., Han, X., Chen, H., Wei, P., Huang, C., Liu, S., Fan, K., Zhou, L., Liu, Z., Pei, J., and Liu, Y. (2006) Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase. Curr. Pharm. Des. 12, 4555-4564.
39. Yin, Z., Patel, S., Wang, W., Wang, G., Chan, W., Rao, K., Alan, J., Jeyaraj, D., Ngew, X., Patel, V., Beer, D., Lim, S., Vasudevan, S., and Keller, T. (2006) Peptide inhibitors of dengue virus NS3 protease. Part 1: Warhead. Bioorg. Med. Chem. Lett. 16, 36-39.
40. Steinhuhler, C., Biasiol, G., Brunetti, M., Urbani, A., Koch, U., Cortese, R., Pessi, A., and De Francesco, R. (1998) Product inhibition of the hepatitis C virus NS3 protease. Biochemistry 37, 8899-8905.
41. DeLano, W. L. (2007) The PyMOL Molecular Graphics System, DeLano Scientific LLC, Palo Alto, CA, http://www.pymol.org.